Position in GSK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$414,380
-$18,585 QoQ
Shares Held
7,905
+0.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#520
of 1,033 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cetera Trust Company, N.A holds $8,988,212 across 12 Drug Manufacturers - General names. GSK ranks #7 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
8,983 | $3,252,923 | |
| 2 | LLY |
ELI LILLY & Co
|
2,087 | $2,503,210 | |
| 3 | MRK |
Merck & Co., Inc.
|
7,054 | $906,439 | |
| 4 | NVS |
Novartis AG
|
3,252 | $509,653 | |
| 5 | AZN |
Astrazeneca PLC
|
2,369 | $449,209 | |
| 6 | JNJ |
Johnson & Johnson
|
1,694 | $430,225 | |
| 7 | GSK |
GSK plc
This page
|
7,905 | $414,380 | |
| 8 | SNY |
Sanofi
|
6,910 | $294,780 |
All Filings in GSK
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $414,380 | 7,905 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $432,965 | 7,845 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $384,718 | 7,845 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $319,168 | 7,395 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $268,608 | 6,995 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $256,458 | 6,620 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $222,873 | 6,590 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $249,572 | 6,105 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $235,042 | 6,105 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $261,721 | 6,105 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $232,180 | 6,265 | Shares | Sole | 2024-02-01 | |
| No filing history on record for this holder in this stock. | ||||||